Jon Stewart, accompanied by Rep. Carolyn Maloney, D-N,Y., and New York City first responders speaks during a rally on Capitol Hill in September.

Jon Stewart, accompanied by Rep. Carolyn Maloney, D-N,Y., and New York City first responders speaks during a rally on Capitol Hill in September. Lauren Victoria Burke/AP

The Biggest Health-Care Winners in the Omnibus Deal

The package includes funding for NIH and 9/11 responders, and delays the “Cadillac Tax” on pricey health plans.

The $1.1 tril­lion spend­ing bill and tax ex­tenders pack­age un­veiled Tues­day and early Wed­nes­day morn­ing is the fi­nale to weeks of lob­by­ing and spec­u­la­tion on a host of is­sues—par­tic­u­larly health care. There are some big win­ners in the year-end bills, in­clud­ing 9/11 first re­spon­ders and sur­viv­ors, Ca­dillac tax op­pon­ents and pos­sibly Sen. Marco Ru­bio. Here’s a closer look:

Za­d­roga Act

The om­ni­bus funds the pro­gram provid­ing health be­ne­fits for 9/11 first re­spon­ders and sur­viv­ors sickened by tox­ic air at the at­tack site through 2090. Also, it reau­thor­izes the Vic­tim Com­pens­a­tion Fund for five years.

Re­new­ing the le­gis­la­tion, known as the Za­d­roga Act, was the cen­ter of a massive lob­by­ing ef­fort in­volving, for one group, at least 22 trips to Wash­ing­ton (with crews of any­where from 12 to 50 people) and an es­tim­ated 600 meet­ings for John Feal, pres­id­ent and founder of the 9/11 ad­vo­cacy group Feal­Good Found­a­tion. It’d been the sub­ject of ral­lies, press con­fer­ences and a seg­ment on The Daily Show, fea­tur­ing a power­ful ad­voc­ate for the bill, Jon Stew­art.

“We’ve met with some mem­bers of the Sen­ate and Con­gress four, five, six times,” Feal told Na­tion­al Journ­al after a press con­fer­ence last week. “Every time we got close, they move the goal­post back on us. Every time we got to the one-yard line, they just kept mov­ing it back, and this time they can’t go nowhere. We’re con­fid­ent we’re go­ing to get it done.” Feal was right.

Obama­care taxes

Re­peal­ing the Ca­dillac tax levied on pricey em­ploy­er-sponsored health cov­er­age has net­ted bi­par­tis­an and bicam­er­al sup­port—and law­makers look­ing to in­clude a two-year delay of the Ca­dillac tax in an om­ni­bus bill got their wish.

Ori­gin­ally slated to start in 2018, the Ca­dillac tax has seen both Demo­crats and Re­pub­lic­ans op­pose the meas­ure. For ex­ample, an amend­ment to re­peal the tax eas­ily passed the Sen­ate in 90 to 10 vote earli­er this month (though it was tacked onto a re­con­cili­ation bill, which Obama won’t sign). But as re­cently as last Wed­nes­day, White House Press Sec­ret­ary Josh Earn­est said the ad­min­is­tra­tion strongly op­poses re­peal­ing the Ca­dillac tax.

Sen. Mark Warner’s wor­ries on the Ca­dillac tax fo­cus on mak­ing sure the fin­an­cing re­mains to sup­port the pricey parts of the law, such as Medi­caid ex­pan­sion. “In a state like mine where we haven’t ex­pan­ded Medi­caid … you give a lot of fod­der if you start tak­ing away the pay-fors,” the Vir­gin­ia Demo­crat told Na­tion­al Journ­alearli­er this month.

Ad­di­tion­ally, the tax ex­tenders deal in­cludes a two year morator­i­um on the med­ic­al device tax, and the om­ni­bus con­tains a one-year morator­i­um on the an­nu­al ex­cise tax on health in­surers for 2017.

Risk cor­ridors 

The risk cor­ridor pro­gram will again be han­di­capped if the om­ni­bus passes and is signed in­to law as stands, as pro­vi­sion stuck in last year’s bill was again in­cluded.

Risk cor­ridors com­pensate in­sur­ance com­pan­ies that sign up sick­er pa­tients than they an­ti­cip­ated and, in turn, are faced with hefty costs. In part, this is be­cause the Af­ford­able Care Act con­tains pri­cing re­stric­tions—such as ban­ning in­surers from char­ging more based on a con­sumer’s med­ic­al his­tory. So, some com­pan­ies are re­quired to pay in­to the risk cor­ridors pro­gram, and oth­ers can col­lect.

Re­pub­lic­ans view this as a bail­out for in­sur­ance com­pan­ies. Last year’s crom­ni­bus con­tained re­stric­tions for the pro­gram, which is slated to last un­til 2016. And in Oc­to­ber, the Cen­ters for Medi­care and Medi­caid Ser­vices an­nounced it would be dol­ing out only a frac­tion of what in­sur­ance com­pan­ies asked for: $362 mil­lion of the $2.87 bil­lion in in­sur­ance claims.

Sen. Marco Ru­bio’s cam­paign is tout­ing last year’s risk cor­ridors re­stric­tions as a Ru­bio vic­tory. A tweet last week from Ru­bio’s ac­count said, “Every­one run­ning wants to dis­mantle Obama­care. I’ve ac­tu­ally done something to­ward achiev­ing that goal,” link­ing to a post on his site with aNew York Times story titled, “Marco Ru­bio Quietly Un­der­mines Af­ford­able Care Act.”

But an As­so­ci­ated Press story has a dif­fer­ent take. It looks at last year’s crom­ni­bus ne­go­ti­ations, say­ing that al­though Ru­bio was one of the first law­makers to rail against risk cor­ridors, he wasn’t solely or ne­ces­sar­ily the one re­spons­ible for last year’s deal.

A sum­mary of the om­ni­bus bill praises last year’s bill for be­ing “able to save over $2.5 bil­lion from po­ten­tially be­ing trans­ferred out of pri­or­ity dis­cre­tion­ary HHS pro­grams fund­ing in the Labor/HHS ap­pro­pri­ations bill to bail­out the Risk Cor­ridor pro­gram es­tab­lished by the Af­ford­able Care Act (ACA).”

Na­tion­al In­sti­tutes of Health

The na­tion’s med­ic­al re­search agency could see the largest boost in fund­ing since fisc­al 2003 with the in­clu­sion of a $2 bil­lion in­crease in funds.

While fund­ing NIH isn’t gen­er­ally con­ten­tious, how much the agency re­ceives comes down to Con­gress’ pri­or­it­ies. Over the course of five years, Con­gress doubled NIH’s fund­ing to $27.1 bil­lion in Fisc­al Year 2003, ac­cord­ing to the Con­gres­sion­al Re­search Ser­vice. But fund­ing hasn’t in­creased at the same pace since, and some Demo­crats and Re­pub­lic­ans alike had called for that to change, a call that was answered in the om­ni­bus bill with NIH slated to re­ceive $32 bil­lion.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.